Teicoplanin Dosing in Adults
For standard adult dosing, administer a loading dose of 6 mg/kg every 12 hours for three doses (or 12 mg/kg for serious infections like endocarditis or septic arthritis), followed by maintenance dosing of 6 mg/kg (or 12 mg/kg for serious infections) once daily, adjusted for renal function. 1
Loading Dose Regimen
The critical principle with teicoplanin is that a loading dose is mandatory on the first day of administration 1. The loading strategy differs based on infection severity:
- Standard infections: 6 mg/kg administered three times (typically every 12 hours on Day 1 and once on Day 2)
- Serious infections (S. aureus endocarditis, septic arthritis, severe bone/joint infections): 12 mg/kg administered three times 1
Recent evidence suggests conventional loading regimens are insufficient for rapid therapeutic target attainment. In hematological malignancy patients and those with preserved renal function, five loading doses of 12 mg/kg every 12 hours may be necessary to achieve trough concentrations ≥20 mg/L within 72 hours 2. For sepsis patients, an 800 mg loading dose every 12 hours has shown improved probability of target attainment 3.
Maintenance Dose and Interval
After loading, maintenance dosing is 6 mg/kg once daily for standard infections or 12 mg/kg once daily for serious infections 1. The dosing interval must be adjusted based on glomerular filtration rate (GFR):
- GFR >90 mL/min: Every 24 hours
- GFR 50-90 mL/min: Every 24 hours
- GFR 10-50 mL/min: Every 48 hours
- GFR <10 mL/min: Every 72 hours 1
Special Populations
Hemodialysis patients: 12 mg/kg loading dose, then 6 mg/kg on days 2 and 3, followed by 6 mg/kg weekly 1. However, newer data suggests this standard regimen achieves only 13.6% probability of target attainment after the first dose. An optimized regimen of 1600 mg loading dose followed by 800 mg maintenance (1200 mg for 3-day interdialytic periods) significantly improves target attainment to 71.7% 4.
CAPD peritonitis: Follow GFR <10 dosing for IV administration, or use intraperitoneal dosing at 20 mg/L in each bag (first week), then every other bag (second week), then night bag only (third week) 1.
CVVH/CAVH: Use dosing as per GFR 10-50 mL/min 1. For sepsis patients on CRRT, males require 800 mg q12h loading followed by 800 mg q24h maintenance; females need 1000 mg q12h loading followed by 1000 mg q24h maintenance 3.
Augmented renal clearance (CrCl >130 mL/min): Standard dosing is inadequate. Use 800 mg loading dose every 12 hours for three doses, followed by 800 mg daily for severe infections or 600-400 mg daily for mild infections 5.
Body Weight Considerations
Dosing should be adjusted based on body composition:
- Underweight patients (BMI <18.5): Increase loading doses by approximately 20% above standard ABW-based dosing 6
- Normal weight patients (BMI 18.5-25): Use actual body weight (ABW) for calculations 6
- Obese patients (BMI ≥25): Decrease loading doses by approximately 20%; use standard body weight (SBW) or ideal body weight (IBW) rather than ABW to prevent overexposure 6
Therapeutic Drug Monitoring
Unlike vancomycin, routine monitoring is NOT recommended by the manufacturer 1. However, monitoring is indicated in specific situations:
When to Monitor:
- S. aureus endocarditis or septic arthritis (target trough ≥20 mg/L, not 10 mg/L) 1
- Major burns 1
- Intravenous drug users 1
- Rapidly changing renal function 1
- Patients on CRRT or hemodialysis 4
Target Concentrations:
- Standard infections: Trough 10-15 mg/L
- Serious infections (endocarditis, osteomyelitis, septic arthritis): Trough ≥20 mg/L 1
- Optimal therapeutic range: 15-30 mg/L 7
Real-world data shows that only 40.8% of patients on 6 mg/kg maintenance achieve trough ≥20 mg/L, compared to 86.6% on 12 mg/kg 8. This supports using higher maintenance dosing (10-12 mg/kg) for serious infections.
Common Pitfalls
Omitting the loading dose: This is the most critical error. Teicoplanin has a long half-life and requires aggressive loading to achieve therapeutic levels rapidly 1.
Underdosing in preserved renal function: Patients with normal or augmented renal clearance frequently fail to achieve therapeutic targets with standard regimens 8, 5, 2.
Using ABW in obese patients: This leads to excessive dosing and potential toxicity. Use IBW or SBW instead 6.
Inadequate dosing in hemodialysis: The traditional weekly dosing achieves subtherapeutic levels. Consider the intensified regimen with predialysis TDM 4.
Assuming monitoring is unnecessary: While not routine, TDM is essential for serious infections and special populations to ensure adequate exposure 1, 8.